D. Bouhassira, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, vol.136, issue.3, pp.380-387, 2008.
DOI : 10.1016/j.pain.2007.08.013

URL : https://hal.archives-ouvertes.fr/inserm-00326893

F. Lecomte, N. Gault, V. Koné, C. Lafoix, C. Ginsburg et al., Prevalence of neuropathic pain in emergency patients: an observational study, The American Journal of Emergency Medicine, vol.29, issue.1, pp.43-49, 2011.
DOI : 10.1016/j.ajem.2009.07.009

H. Merskey and N. Bogduk, classification of chronic pain. Descriptions of chronic pain syndromes and definition of terms, 1994.

D. Bouhassira and N. Attal, Mécanismes physiopathologiques, Rueil Malmaison, vol.4, pp.49-50, 2007.

G. Cruccu, P. Anand, N. Attal, M. Hanpaa, E. Jorum et al., EFNS guidelines on neuropathic pain assessment, European Journal of Neurology, vol.12, issue.3, pp.153-62, 2004.
DOI : 10.1016/0304-3959(94)00132-X

T. Jensen and . Hanssonp, Chapter 34 Classification of neuropathic pain syndromes based on symptoms and signs, Handbook of clinical neurology, vol.81, pp.517-546, 2006.
DOI : 10.1016/S0072-9752(06)80038-2

T. Jensen and R. Baron, Translation of symptoms and signs into mechanisms in neuropathic pain, Pain, vol.102, issue.1, pp.1-8, 2003.
DOI : 10.1016/s0304-3959(03)00006-x

C. Woolf and R. Mannion, Neuropathic pain, The Lancet, vol.354, issue.9182, pp.1959-64, 1999.
DOI : 10.1016/S0140-6736(05)75705-6

D. Bouhassira and N. Attal, Définitions, classification et diagnostic. Douleurs neuropathiques. Arnette, Ed Rueil Malmaison, vol.1, p.6, 2007.

M. Pal, Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management, Current Pharmaceutical Design, vol.15, issue.9, pp.1008-1034, 2009.
DOI : 10.2174/138161209787581995

G. Mick, What is localised neuropathic pain? A first proposal to characterise and define a widely used term (Qu'est-ce que la douleur neuropathique localisée ?

H. Recommandations, Prise en charge diagnostique des neuropathies périphériques, Mai, vol.8, 2007.

G. Cruccu, C. Sommer, P. Anand, N. Attal, . Baron et al., EFNS guidelines on neuropathic pain assessment, European Journal of Neurology, vol.12, issue.3, pp.1010-1018, 2009.
DOI : 10.1016/0304-3959(94)00132-X

N. Attal, S. Perrot, J. Fermanian, and D. Bouhassira, The Neuropathic Components of Chronic Low Back Pain: A Prospective Multicenter Study Using the DN4 Questionnaire, The Journal of Pain, vol.12, issue.10, pp.1080-1087, 2011.
DOI : 10.1016/j.jpain.2011.05.006

D. Bouhassira and N. Attal, Etiologies et aspects cliniques

K. Schmader, Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy, The Clinical Journal of Pain, vol.18, issue.6, pp.350-354, 2002.
DOI : 10.1097/00002508-200211000-00002

M. Dermott, A. Toelle, T. Rowbotham, D. Schaefer, C. Dukes et al., The burden of neuropathic pain : results from a cross-sectional survey, Eur J Pain, 2006.

R. Van-seventer, A. Sadosky, M. Lucero, and E. Dukes, A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia, Age and Ageing, vol.35, issue.2, pp.132-169, 2006.
DOI : 10.1093/ageing/afj048

G. Oster, G. Harding, E. Dukes, J. Edelsberg, and P. Cleary, Pain, Medication Use, and Health-Related Quality of Life in Older Persons With Postherpetic Neuralgia: Results From a Population-Based Survey, The Journal of Pain, vol.6, issue.6, pp.356-63, 2005.
DOI : 10.1016/j.jpain.2005.01.359

R. Dworkin, M. Backonja, and M. Rowbotham, Advances in Neuropathic Pain, Archives of Neurology, vol.60, issue.11, pp.1524-1558, 2003.
DOI : 10.1001/archneur.60.11.1524

N. Finnerup, M. Otto, and H. Mcquay, Algorithm for neuropathic pain treatment: An evidence based proposal, Pain, vol.118, issue.3, pp.289-305, 2005.
DOI : 10.1016/j.pain.2005.08.013

I. Gilron, C. Watson, C. Cahill, and D. Moulin, Neuropathicpain : a pratical guide for the clinicien, CMAJ, vol.176, pp.265-75, 2006.

T. Jensen, Anticonvulsants in neuropathic pain: rationale and clinical evidence, European Journal of Pain, vol.73, issue.Suppl 6
DOI : 10.1053/eujp.2001.0324

S. Sindrup, M. Otto, and N. Finnerup, Antidepressants in the Treatment of Neuropathic Pain, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.58, issue.6, pp.399-409, 2005.
DOI : 10.1016/S0140-6736(99)01307-0

J. Katz, N. Finnerup, and R. Dworkin, Clinical trial outcome in neuropathic pain: Relationship to study characteristics, Neurology, vol.70, issue.4, pp.263-72, 2008.
DOI : 10.1212/01.wnl.0000275528.01263.6c

I. Gilron, J. Bailey, D. Tu, R. Holden, D. Weaver et al., Morphine, Gabapentin, or Their Combination for Neuropathic Pain, New England Journal of Medicine, vol.352, issue.13, pp.1324-1358, 2005.
DOI : 10.1056/NEJMoa042580

I. Gilron, J. Baley, D. Tu, D. Holdern, A. Jackson et al., Nortritpyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial, Lancet, 2009.

. Equipe-interdisciplinaire-du-centre-d, expertise en gestion de la douleur chronique (CEGDC) associé au réseau universitaire intégré en santé (RUIS) de l'Université de Montréal sous la direction de Dr Aline Boulanger Algorithme de prise en charge de la douleur neuropathique. La Direction des communications du ministère de la Santé et des Services sociaux Disponible sur http, Mars, vol.7, pp.14-947, 2014.

D. Ranoux, N. Attal, F. Morain, and D. Bouhassira, Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain, Annals of Neurology, vol.156, issue.suppl 173, pp.274-84, 2008.
DOI : 10.1002/ana.21427

URL : https://hal.archives-ouvertes.fr/inserm-00292356

V. Martinez, N. Attal, D. Bouhassira, and M. Lantéri-minet, Les douleurs neuropathiques chroniques??: diagnostic, ??valuation et traitement en m??decine ambulatoire. Recommandations pour la pratique clinique de la Soci??t?? fran??aise d?????tude et de traitement de la douleur, Douleurs : Evaluation - Diagnostic - Traitement, vol.11, issue.1, 2010.
DOI : 10.1016/j.douler.2009.12.009

P. Wall and W. Sweet, Temporary Abolition of Pain in Man, Science, vol.155, issue.3758, pp.108-117, 1967.
DOI : 10.1126/science.155.3758.108

L. Chesterton, N. Foster, T. Lundeberg, C. Wright, G. Baxter et al., Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects, Pain, vol.106, issue.1, pp.73-80, 2003.
DOI : 10.1016/S0304-3959(03)00292-6

M. Jensen, Hypnosis for chronic pain management: A new hope, Pain, vol.146, issue.3, pp.235-237, 2009.
DOI : 10.1016/j.pain.2009.06.027

V. Guastella, G. Mick, and B. Laurent, Traitements non m??dicamenteux de la douleur neuropathique, La Presse M??dicale, vol.37, issue.2, pp.354-357, 2008.
DOI : 10.1016/j.lpm.2007.11.008

D. Turk, K. Swanson, and E. Tunks, Psychological approaches in the treatment of chronic pain patients -When pills, scalpels, and needles are not enough, Canadian Journal of Psychiatry, vol.53, pp.213-236, 2008.

D. Clifford, D. Simpson, S. Brown, G. Moyle, B. Brew et al., NGX- 4010 C119 Study Group. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy, Journal of Acquired Immune Deficiency Syndromes, vol.589, issue.2, pp.126-159, 2012.

M. Backonja, M. Wallace, and E. Blonsky, NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, The Lancet Neurology, vol.7, issue.12, pp.1106-1118, 2008.
DOI : 10.1016/S1474-4422(08)70228-X

. Irving, A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia, Pain Medicine, vol.12, issue.1, pp.99-109, 2011.
DOI : 10.1111/j.1526-4637.2010.01004.x

M. Backonja, NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, The Lancet Neurology, vol.7, issue.12, pp.1106-1118, 2008.
DOI : 10.1016/S1474-4422(08)70228-X

D. Simpson, Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy, Neurology, vol.70, issue.24, pp.2305-2318, 2008.
DOI : 10.1212/01.wnl.0000314647.35825.9c

D. Simpson, S. Gazda, and S. Brown, Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain, Journal of Pain and Symptom Management, vol.39, issue.6, pp.1053-64, 2010.
DOI : 10.1016/j.jpainsymman.2009.11.316

/. Disponible-sur-http, . Comm, and . Vendredi, Matin/12-12h20-dr-robard-bordeaux-sfco- 2015-prise-en-charge-des-douleurs-neuropathiques-en-cancerologie.pdf 62. agence française de sécurité sanitaire des produits de santé, 2011.